Rebecca Galante
Internal Medicine · Munster, INNPI 1437133220
Payments from drug & device makers
Across 273 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$661
- Novo Nordisk$521
- Johnson & Johnson$398
- Lilly USA, LLC$359
- AstraZeneca$289
- Merck$222
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,363100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $661 |
| Novo Nordisk | 32 | $521 |
| Johnson & Johnson(2 entities) | 28 | $398 |
| Lilly USA, LLC | 21 | $359 |
| AstraZeneca | 19 | $289 |
| Merck | 15 | $222 |
| Amgen | 13 | $218 |
| Sanofi-aventis U.S. LLC | 13 | $203 |
| Boehringer Ingelheim | 11 | $193 |
| Novartis | 9 | $165 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $109 |
| Amarin Pharma, Inc. | 7 | $102 |
| E.r. Squibb & Sons, L.L.C. | 6 | $89 |
| Pfizer | 4 | $74 |
| Bayer | 4 | $68 |
| Sanofi Pasteur Inc. | 3 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Dexcom, Inc. | 4 | $54 |
| Astellas Pharma US Inc | 3 | $48 |
| Eisai Inc. | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Exact Sciences | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Ironwood Pharmaceuticals, Inc | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Medtronic | 1 | $23 |
| Edwards Lifesciences | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| GSK | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$4,363 in reported general payments places this provider in the 90th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 17 | $19,093 |
| OzempicSemaglutide | 15 | $13,171 |
| FarxigaDapagliflozin Propanediol | 11 | $9,808 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $5,383 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $4,851 |
| SynthroidLevothyroxine Sodium | 28 | $1,632 |
| Levothyroxine Sodium | 105 | $1,172 |
| Atorvastatin Calcium | 89 | $772 |
| Amlodipine Besylate | 86 | $583 |
| Metoprolol Succinate | 30 | $540 |
| Escitalopram Oxalate | 36 | $530 |
| Pantoprazole Sodium | 26 | $483 |
| Losartan Potassium | 54 | $481 |
| Rosuvastatin Calcium | 43 | $429 |
| Omeprazole | 18 | $300 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $222 | $19,09317 claims |
| Novo NordiskOzempic | $521 | $13,17115 claims |
| AstraZenecaFarxiga | $289 | $9,80811 claims |
| AbbVieSynthroid | $661 | $1,63228 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $24 | $1,172105 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Munster
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.